News

The Pharma Letter2h
The week in pharma: action, reaction and insight – week to May 23
Last week saw Novavax receive full approval from the US Food and Drug Administration (FDA) for its COVID-19 vaccine, but with ...
The Pharma Letter23h
Gilead says Trodelvy ASCENT-03 study meets primary endpoint
US antivirals major Gilead Sciences (Nasdaq: GILD) yesterday released positive top-line results from the Phase III ASCENT-03 ...